U.S. OKs treatment that would ‘reprogram a patient’s own cells to attack a deadly cancer’

Opening a new era in cancer care, the U.S. Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients’ own blood cells into an army of assassins to seek and destroy childhood leukemia.